Subcutaneous Fat Clinical Trial
Official title:
Diagnostic Ultrasound for Measuring Fat of the Body
Verified date | September 2023 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to provide information about human subcutaneous fat thickness at different anatomic sites on the body by measuring these thicknesses with a diagnostic ultrasound and also by correlating patient perceptions of body image with measured fat distribution. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Status | Completed |
Enrollment | 40 |
Est. completion date | October 2, 2022 |
Est. primary completion date | October 2, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - Males or females 18-85 years old. - Subjects are in good health as judged by the investigator. - Subjects with Body Mass Index (BMI) between 18-29.99. - Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator Exclusion Criteria: - Evidence of another skin condition affecting the treatment area that would interfere with clinical assessments - Pregnant or breast feeding - Uncooperative patients or patients with neurological disorders who are incapable of following directions - Subjects who are unable to understand the protocol or give informed consent (including non-English speaking patients) |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern University Department of Dermatology | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in Thickness of Subcutaneous Fat at Different Anatomic Sites on the Body | Will use diagnostic ultrasound to measure fat thickness | through study completion, 1 day | |
Primary | Gender Differences on Patient Perceptions of Body Image With Measured Fat Distribution | Will use diagnostic ultrasound to measure fat thickness and a questionnaire to assess subject perceptions of their body using a 10-point Likert scale (1= very unsatisfied, 10= very satisfied) | through study completion, 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04699669 -
A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02512822 -
Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring
|
N/A | |
Active, not recruiting |
NCT06005441 -
A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
|
Phase 2 | |
Active, not recruiting |
NCT05736107 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
|
Phase 2 | |
Not yet recruiting |
NCT03160976 -
Cryolipolysis on Localized Adiposity
|
N/A | |
Completed |
NCT02098811 -
Evaluation of the Safety and Precursors of Efficacy
|
N/A | |
Active, not recruiting |
NCT04553627 -
Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis
|
N/A | |
Completed |
NCT02539043 -
Effects of Ultrasound Cavitation Focused on Located Adiposity
|
N/A | |
Completed |
NCT01842802 -
Clinical Investigation of Non Invasive Fat Reduction
|
N/A | |
Completed |
NCT04698642 -
A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat
|
Phase 2 | |
Completed |
NCT02052622 -
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
|
Phase 3 | |
Completed |
NCT04897412 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2)
|
Phase 2 | |
Completed |
NCT03682471 -
Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
|
||
Completed |
NCT05234736 -
A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers
|
Phase 2 | |
Completed |
NCT04575467 -
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
|
Phase 2 |